We would like to ask you about your experience regarding your treatment with IV Bebtelovimab (monoclonal antibodies.) Please only answer this survey if you have received this particular type of monoclonal antibodies, which is the most recent one approved for treatment in patients with COVID19.  All answers will be kept strictly confidential.  Thank you for helping us understand how effective this treatment is for patients with COVID-19.

Question Title

* 1. What is your age?

Question Title

* 2. What is your gender?

Question Title

* 3. Which is your race?

Question Title

* 4. Have you had COVID before (check all that apply)?

Question Title

* 5. What is your vaccination status?

Question Title

* 6. When was your last COVID shot?

Question Title

* 7. How long ago did you receive IV Bebtelovimab?

Question Title

* 8. Where did you receive treatment?

Question Title

* 9. On the day of your treatment, how severe were your symptoms?

Question Title

* 10. Which of the following best describes your response?

Question Title

* 11. Please indicate which of the following apply to you:

Question Title

* 12. Please indicate which of these treatments you took in addition to monoclonal antibodies.

Question Title

* 13. If you took ivermectin and/or hydroxychloroquine, when did you start taking these additional medications?

Question Title

* 14. If you took Ivermectin and/or hydroxychloroquine, which of the following applies?

Question Title

* 15. Please indicate any side effects that you experienced after your IV monoclonal antibodies.

Question Title

* 16. Would you recommend IV Bebtelovimab to a loved one with COVID-19?

T